Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_assertion type Assertion NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_head.
- NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_assertion description "[Collectively, these findings suggested that the antimetastatic properties of CLT in breast cancer were due to the inhibition of MMPs, which might be associated with a downregulation of Runx2 transcriptional activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_provenance.
- NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_assertion evidence source_evidence_literature NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_provenance.
- NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_assertion SIO_000772 25190326 NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_provenance.
- NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_assertion wasDerivedFrom befree-2016 NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_provenance.
- NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_assertion wasGeneratedBy ECO_0000203 NP1217164.RAZ-3oJgvN1CWLO-1Ecl-AJ-P3lEKhkZOLrHQMyd6SlVI130_provenance.